Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam and Remifentanil for AV Fistula Placement
NCT04226443Completed
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Aug 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of midazolam in chronic kidney disease (CKD) (2 arms), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Primary endpoints: Total amount of midazolam consumption up to 2 hours, Total amount of remifentanil consumption up to 2 hours and 2 more. Started Aug 2012; status: completed.
02
Drugs
midazolam
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04226443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04226443.